Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, in its acquisition of Advanced Cell Diagnostics (ACD), a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. The transaction closed on August 1, 2016.
Fredrikson’s legal team was led by Ryan Brauer, Zach Olson and Sarah Tucher.
Read the news release.
